Literature DB >> 24526735

Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer.

Tobias Lange1, Mareike Kupfernagel, Daniel Wicklein, Florian Gebauer, Hanna Maar, Kathrin Brügge, Imke Müller, Ronald Simon, Thorsten Schlomm, Guido Sauter, Udo Schumacher.   

Abstract

PURPOSE: To investigate the impact of prostate cancer cell surface glycosylation as part of the tumor cell-endothelial cell interaction in prostate cancer metastasis. EXPERIMENTAL
DESIGN: Glycosyltransferase expression was profiled in metastasis-derived prostate cancer cell lines and compared with primary epithelium. Prostate cancer cells were examined for HPA- and selectin-binding and adhesion to endothelium. Spontaneous metastasis xenograft models were established to test the lectin HPA-binding sites as a marker of metastatic competence and to evaluate E-selectin-binding sites in vivo. The importance of selectins for metastasis formation was analyzed using Sele(-/-)/Selp(-/-) mice. The clinical relevance of HPA- and E-selectin-binding sites in prostate cancer was determined.
RESULTS: Glycosyltransferases involved in the synthesis of common HPA-binding sites are downregulated in prostate cancer cells. An absence of HPA-reactive carbohydrates specifically indicates spontaneous metastatic spread of prostate cancer xenografts in vivo and a poor prognosis of patients with prostate cancer. HPA-binding sites decrease in lymph node metastases compared with corresponding primary tumors. Common selectin ligands are absent on prostate cancer cells, which do not adhere to recombinant selectins or endothelium under shear stress in vitro. Spontaneous metastasis formation is largely independent of selectins in vivo. E-selectin-binding sites are detectable in only 2% of patients with prostate cancer without prognostic significance.
CONCLUSION: Prostate cancer is characterized by an inverse functional and prognostic importance of HPA-binding sites compared with other adenocarcinomas. Accordingly, this study surprisingly shows that the selectin-selectin ligand axis, which is essential for extravasation and thus metastasis formation in several malignancies, can be circumvented in prostate cancer. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24526735     DOI: 10.1158/1078-0432.CCR-13-2308

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  12 in total

1.  Tumor cell E-selectin ligands determine partialefficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo.

Authors:  Tobias Lange; Ursula Valentiner; Daniel Wicklein; Hanna Maar; Vera Labitzky; Ann-Kristin Ahlers; Sarah Starzonek; Sandra Genduso; Lisa Staffeldt; Carolin Pahlow; Anna-Maria Dück; Christine Stürken; Anke Baranowsky; Alexander T Bauer; Etmar Bulk; Albrecht Schwab; Kristoffer Riecken; Christian Börnchen; Rainer Kiefmann; Valsamma Abraham; Horace M DeLisser; Timo Gemoll; Jens K Habermann; Andreas Block; Klaus Pantel; Udo Schumacher
Journal:  Mol Ther       Date:  2022-01-12       Impact factor: 12.910

2.  CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

Authors:  Niklas Mueller; Daniel Wicklein; Gregor Eisenwort; Mohamad Jawhar; Daniela Berger; Gabriele Stefanzl; Georg Greiner; Alexandra Boehm; Christoph Kornauth; Leonhard Muellauer; Susanne Sehner; Gregor Hoermann; Wolfgang R Sperr; Philipp B Staber; Ulrich Jaeger; Johannes Zuber; Michel Arock; Udo Schumacher; Andreas Reiter; Peter Valent
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

3.  ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.

Authors:  Junjian Wang; June X Zou; Xiaoqian Xue; Demin Cai; Yan Zhang; Zhijian Duan; Qiuping Xiang; Joy C Yang; Maggie C Louie; Alexander D Borowsky; Allen C Gao; Christopher P Evans; Kit S Lam; Jianzhen Xu; Hsing-Jien Kung; Ronald M Evans; Yong Xu; Hong-Wu Chen
Journal:  Nat Med       Date:  2016-03-28       Impact factor: 53.440

4.  Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.

Authors:  Tobias Lange; Su Jung Oh-Hohenhorst; Simon A Joosse; Klaus Pantel; Oliver Hahn; Tobias Gosau; Sergey A Dyshlovoy; Jasmin Wellbrock; Susanne Feldhaus; Hanna Maar; Renate Gehrcke; Martina Kluth; Ronald Simon; Thorsten Schlomm; Hartwig Huland; Udo Schumacher
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

Review 5.  The role of glycans in the development and progression of prostate cancer.

Authors:  Jennifer Munkley; Ian G Mills; David J Elliott
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

6.  Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.

Authors:  Tanja Spethmann; Lukas Clemens Böckelmann; Vera Labitzky; Ann-Kristin Ahlers; Jennifer Schröder-Schwarz; Sarah Bonk; Ronald Simon; Guido Sauter; Hartwig Huland; Robert Kypta; Udo Schumacher; Tobias Lange
Journal:  Mol Oncol       Date:  2021-02-17       Impact factor: 6.603

7.  Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.

Authors:  Lifang Yang; Sucharita M Dutta; Dean A Troyer; Jefferson B Lin; Raymond A Lance; Julius O Nyalwidhe; Richard R Drake; O John Semmes
Journal:  Oncotarget       Date:  2015-12-22

8.  Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.

Authors:  Thorsten Frenzel; Bertin Hoffmann; Rüdiger Schmitz; Anja Bethge; Udo Schumacher; Gero Wedemann
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

Review 9.  Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.

Authors:  Takeshi Namekawa; Kazuhiro Ikeda; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Cells       Date:  2019-01-20       Impact factor: 6.600

10.  Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma.

Authors:  Ursula Valentiner; Jillian Knips; Ralph Pries; Till Clauditz; Adrian Münscher; Guido Sauter; Barbara Wollenberg; Udo Schumacher
Journal:  Cancers (Basel)       Date:  2019-10-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.